Home » Topics » Disease categories and therapies » Immune

Immune
RSS

FDA to review generic immunosuppressant

Jan. 27, 1997

Peptide Therapeutics and Medeva collaborate on vaccine development

Jan. 27, 1997

NIH offers licenses for conjugate vaccine

Jan. 23, 1997

Anti-CD11a MAb enters clinical trials for second indication

Jan. 22, 1997

Aquila adjuvant shows promise as component of malaria vaccine

Jan. 20, 1997

Anti-IL-2 monoclonal antibody described by Ajinomoto

Jan. 20, 1997

Obstacles to tolerance induction in the treatment of autoimmune disease

Jan. 17, 1997

Betafectin clinical update

Jan. 13, 1997

AutoImmune initiates clinical trials in transplant rejection

Jan. 13, 1997

Kimmel Cancer Center's immunological disease therapy progress

Jan. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...